Post-Approval Study of MelaFind
Terminated
- Conditions
- Melanoma
- First Posted Date
- 2012-10-04
- Last Posted Date
- 2016-03-11
- Lead Sponsor
- MELA Sciences, Inc.
- Target Recruit Count
- 487
- Registration Number
- NCT01700114
- Locations
- ๐บ๐ธ
AboutSkin Dermatology and DermSurgery, Englewood, Colorado, United States
๐บ๐ธDermatology Associates of Tallahassee, Tallahassee, Florida, United States
๐บ๐ธThe Johns Hopkins University, Baltimore, Maryland, United States
MelaFind Evaluations for Patients With Multiple Nevi
Completed
- Conditions
- Clinically Atypical Pigmented Skin Lesion
- First Posted Date
- 2012-10-04
- Last Posted Date
- 2014-08-26
- Lead Sponsor
- MELA Sciences, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT01700101
Does the Aid of MelaFind Affect Clinical Management Decisions
Completed
- Conditions
- Melanoma
- First Posted Date
- 2011-07-04
- Last Posted Date
- 2014-11-14
- Lead Sponsor
- MELA Sciences, Inc.
- Target Recruit Count
- 227
- Registration Number
- NCT01387581
- Locations
- ๐บ๐ธ
MELA Sciences, Irvington, New York, United States
Survey Study - Sensitivity Comparison Between MelaFind and Physician Group
Completed
- Conditions
- Melanoma
- First Posted Date
- 2009-11-11
- Last Posted Date
- 2012-02-14
- Lead Sponsor
- MELA Sciences, Inc.
- Target Recruit Count
- 241
- Registration Number
- NCT01011153
Evaluation of Pigmented Skin Lesions With MelaFind(R) System
Phase 3
Completed
- Conditions
- Melanoma
- Interventions
- Device: MelaFind(R)
- First Posted Date
- 2007-02-12
- Last Posted Date
- 2012-02-14
- Lead Sponsor
- MELA Sciences, Inc.
- Target Recruit Count
- 1383
- Registration Number
- NCT00434057
- Locations
- ๐บ๐ธ
Skin and Cancer Associates, Plantation, Florida, United States
๐บ๐ธDermatology Associates of Tallahassee, Tallahassee, Florida, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath